Freiberg R A, Ho S N, Khavari P A
Dermatology Service, VA Palo Alto Health Care System, Palo Alto, California 94304, USA.
J Clin Invest. 1997 Jun 1;99(11):2610-5. doi: 10.1172/JCI119449.
The skin is an attractive tissue for regulated target gene expression by virtue of its accessibility to topical regulating stimuli. We have used synthetic ligand-driven intracellular oligomerization to accomplish specific target gene regulation in human skin keratinocytes and fibroblasts. GAL4 DNA binding domains and VP16 transactivation domains, each linked to the FK506 binding protein, were expressed in normal human skin keratinocytes and fibroblasts. These hybrid proteins underwent heterodimerization via the novel intracellular dimerizing agent FK1012 to generate a heterodimeric activator of target gene expression in vitro. Dimeric FK1012, but not monomeric FK506M induced target gene expression in a dose-dependent fashion. FK1012 exerted no detectable nonspecific effects on expression of cutaneous genes and did not alter cellular proliferation kinetics. Controlled oligomerization of hybrid transcription activators offers a potential approach to target gene regulation in cells of normal human skin.
由于皮肤易于接受局部调节刺激,因此它是用于调控靶基因表达的理想组织。我们利用合成配体驱动的细胞内寡聚化来实现对人皮肤角质形成细胞和成纤维细胞中特定靶基因的调控。将分别与FK506结合蛋白相连的GAL4 DNA结合结构域和VP16反式激活结构域在正常人皮肤角质形成细胞和成纤维细胞中表达。这些杂合蛋白通过新型细胞内二聚化剂FK1012进行异源二聚化,从而在体外产生靶基因表达的异源二聚体激活剂。二聚体FK1012而非单体FK506M以剂量依赖性方式诱导靶基因表达。FK1012对皮肤基因的表达未产生可检测到的非特异性影响,也未改变细胞增殖动力学。杂合转录激活剂的可控寡聚化为正常人皮肤细胞中的靶基因调控提供了一种潜在方法。